The estrogen receptor coactivator AIB1 is a new putative prognostic biomarker in ER-positive/HER2-negative invasive lobular carcinoma of the breastUlrik Narbe(Lund University), Mårten Fernö(Lund University)Breast Cancer Research and TreatmentFebruary 21, 201910.1007/s10549-019-05138-7Cited by 9SaveCiteExport RISWatch citationsRelated PapersPrior Adjuvant Tamoxifen Treatment in Breast Cancer Is Linked to Increased AIB1 and HER2 Expression in Metachronous Contralateral Breast Cancer|PLoS ONE|2016|11